Shasun Chemicals and drugs, a pharma company specialising in CRAMS and API exports posted a 10.77 per cent growth in consolidated revenue at Rs 887.20 crore for the financial year ended March 31, 2008 compared to Rs 800.93 crore in FY07.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>On a standalone basis, the income from operations grew 13.1 per cent to Rs 481.75 crore compared to Rs 425.82 crore in the previous year. The board of directors has recommended a 50 per cent dividend subject to shareholder's approval. <BR></P></p><p class='TableClas'></p></table>


Shasun Chemicals net down 53% to Rs 24.6 cr

Also Read

Blue Star bags airport airconditioning projects worth Rs 66 cr

CSB posts net profit of Rs 36.56 cr

IVRCL bags Rs 837.6 cr order from ONGC unit

Tata Tea net profit at Rs 178.86 cr

Dabur net dips 14.81% to Rs 98.6 cr in FY08

Explore News